Hydrolyzed rice protein formula to support growth and tolerance in infants with cow's milk protein allergy
Official title: Effect of a Hydrolyzed Rice Protein-based Formula on Growth, Tolerance, and Health-related Quality of Life in Infants With Cow's Milk Protein Allergy: a Randomized Nutritional Clinical Study
Run by Société des Produits Nestlé (SPN) · NCT06633250 · Data updated 2026-11-12
This trial will test whether a hydrolyzed rice protein-based infant formula helps babies with cow's milk protein allergy grow as well and tolerate feeding as well as a control formula.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | Any age to 8 Months |
| Sex | All |
| Enrollment | 104 (estimated) |
| Sponsor | Société des Produits Nestlé (SPN) Industry-sponsored |
| Locations | 19 sites (Berlin and 18 other locations) |
| Status | Recruiting |
| Started | October 25, 2024 |
| Main results expected | August 2026 |
| Study ends | August 2026 |
| Registry record updated | December 26, 2025 |
| Trial ID | NCT06633250 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Term singleton infants aged ≤8 months who are fully formula-fed (no breast milk), have suspected or confirmed CMPA, are on a strict cow's milk elimination diet, and meet the listed birth weight and consent requirements.
✕Probably not a fit
Infants who are still breastfeeding, born preterm, have other serious medical conditions, or require amino-acid-based formulas for severe IgE-mediated allergy are unlikely to benefit from this formula.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Term infants up to 8 months with suspected or confirmed cow's milk protein allergy who are fully formula-fed will receive either a hydrolyzed rice protein-based test formula or a control formula while remaining on a strict cow's milk elimination diet. The main goal is to show that growth on the test formula is not worse than growth on the control formula; gastrointestinal tolerance, health-related quality of life, and formula acceptability will also be recorded. Measurements include growth parameters and parent-reported tolerance and quality-of-life questionnaires collected during follow-up visits at participating pediatric centers. The trial is conducted at tertiary hospitals in Germany and Italy and is sponsored by a commercial formula manufacturer.
Why it matters
Potential benefit: If successful, this formula could offer a well-tolerated, non-dairy option that supports normal growth in infants with cow's milk protein allergy.
How similar studies have gone: Previous smaller studies and clinical experience suggest hydrolyzed rice-based formulas can support growth and are tolerated by many infants with CMPA, but the evidence base is smaller than for extensively hydrolyzed cow's milk or amino-acid formulas.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Written informed consent has been obtained from at least one parent (or legally acceptable representative \[LAR\]), if applicable) 2. Infant gestational age ≥ 37 completed weeks 3. Infant birth weight of ≥ 2.5 kg and ≤ 4.5 kg 4. Singleton birth 5. Infant age ≤ 8 months 6. Mother has previously decided to fully formula-feed, and infant is no longer breastfeeding or receiving breast milk 7. Suspected CMPA as per standard clinical practice and in conjunction with at least 2 symptoms present from the list shown below: 1. Inconsolable crying, regurgitation, liquid stools or constipation, skin atopic lesion, cow's milk provoked temporary urticaria/angioedema or vomiting, bloody streaks in stool, or respiratory symptoms 2. For diagnosis based on either a positive IgE blood test, skin prick test or food challenge, only at least 1 symptom from above list needs to be present 8. Infant is receiving a strict cow's milk elimination diet and will continue receiving this diet until the completion of the study 9. Infant's parent(s)/LAR is of legal age of majority, must have parental authority, must understand the informed consent form and other study documents, and is willing and able to fulfill the requirements of the study protocol Exclusion Criteria: 1. History of intolerance to eHF formula 2. Any chronic medical diseases (except atopic eczema), chromosomal or major congenital anomalies (based on medical history and/or commonly performed diagnostic criteria) 3. Major gastrointestinal disease / abnormalities (other than CMPA) 4. Known or suspected lactose intolerance or malabsorption 5. Known or suspected soy allergy 6. Glucose-galactose malabsorption 7. Rice protein allergy or intolerance (e.g., rice protein-induced enterocolitis syndrome). 8. Immunodeficiency 9. Persistent wheeze or chronic respiratory disease 10. Severe uncontrolled eczema 11. History of severe anaphylactic reaction (e.g., requiring ≥ 2 doses of epinephrine) to cow's milk or breast milk at any time prior to enrollment 12. Weight-for-age value \< -2 or \> 2 standard deviations from the WHO Child Growth Standards median at enrollment 13. Height-for-age \< -2 or \> 2 standard deviations from the WHO Child Growth Standards median at enrollment 14. Infant's parent has other medical or psychiatric condition that, in the judgement of the investigator, would make the infant inappropriate for entry into the study 15. Currently participating or having participated in another interventional clinical study within 4 weeks prior to enrollment
Where it's running
-
Charité Universitätsmedizin Berlin
Berlin, Germany Recruiting -
Azienda Ospedaliera Universitaria Federico II
Naples, Italy Recruiting -
Azienda Ospedaliero Universitaria di Parma
Parma, Italy Recruiting -
AO Ordine Mauriziano
Turin, Italy Recruiting -
Poliklinika Ginekologiczno-Położnicza Arciszewscy
Bialystok, Poland Recruiting -
Centrum Medyczne Pratia
Bydgoszcz, Poland Recruiting
Show 13 more locations
-
IN-VIVO Bydgoszcz
Bydgoszcz, Poland Recruiting -
Prywatna Praktyka Lekarska Gabinet Pediatryczno-Alergologiczny
Bydgoszcz, Poland Recruiting -
Vitamed Galaj i Cichomski
Bydgoszcz, Poland Recruiting -
BioMedical Centers
Janki, Poland Recruiting -
Jagiellonian University Medical College
Krakow, Poland Recruiting -
Wojewodzki Szpital Specjalistyczny im. M. Kopernika
Lodz, Poland Recruiting -
ETG Lublin
Lublin, Poland Recruiting -
Korczowski Bartosz Gabinet Lekarski
Rzeszów, Poland Recruiting -
Alergo-Med Specjalistyczna Przychodnia Lekarska
Tarnów, Poland Recruiting -
AOUP Ospedale Santa Chiara
Pisa, Italy Completed -
Ospedale Pediatrico Bambino Gesu
Rome, Italy Not yet recruiting -
Centrum Medyczne Plejady
Krakow, Poland Completed -
University Hospital of Warsaw
Warsaw, Poland Completed
Study contacts
- Study coordinator: Anthony de COZAR
- Email: anthony.decozar@rd.nestle.com
- Phone: +41762627426
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Stepwise introduction of heat-treated cow's milk to build tolerance after previous treatment didn't work
We will follow children with cow's milk allergy who can drink heated milk but still react to regular milk to see how long it takes them to become fully tolerant.
-
Hydrolysed rice protein formula for infants with cow's milk allergy
This study is testing if a new rice-based formula can safely help infants with cow's milk allergy grow and feel better compared to a standard formula made from cow's milk protein.
-
Extensively hydrolysed whey formula with synbiotics and 2'-FL for infants with cow's milk protein allergy
This study tests whether an extensively hydrolysed whey-based infant formula with synbiotics and the human milk sugar 2'-fucosyllactose (2'-FL) helps infants under 10 months who have suspected or confirmed cow's milk protein allergy.
-
Remibrutinib for IgE-mediated peanut, milk, and egg allergy
This study tests whether remibrutinib can help people with peanut, milk, or egg allergies by comparing it to placebo over 52 weeks.
-
Assessing milk ladders for children with cow's milk protein allergy
This study is testing two different milk ladder plans to see which one helps young children with a cow's milk allergy tolerate milk better.
-
Introducing heated cow's milk to help children with milk allergies develop tolerance
This study is testing if slowly introducing less heated cow's milk to children with milk allergies can help them develop a tolerance faster and improve their quality of life.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.